Select your country or region to view content specific to your country.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Oct 28, 2021
Seegene
and the Seegene Medical Foundation donate testing reagents and expenses
for constant diagnosis of COVID-19 in kind to KAIST (Korea Advanced Institute
of Science and Technology).
On October 28, a ceremony was held at KAIST's main
campus in Daejeon for the donation of COVID-19 testing reagent in kind by the
Seegene and Seegene Medical Foundation. The donation ceremony was held in the
presence of about 10 people, including Seegene CEO Chun Jong-yoon, Seegene
Medical Foundation Chairman Chun Jong-ki, KAIST President Lee Kwang-hyung,
Provost and Executive Vice President Lee Seung-seop, and Vice President for
Planning and Budget Kim Bo-won.
This
donation was made based on the consensus between the two organizations to
quickly prepare for the transition into new ‘Living with Covid-19’ policy,
which will be implemented from the 1st of next month, and the business
agreement signed in July. The purpose is to prevent the spread of COVID-19 at
an early stage and support safe return to daily life by establishing a
'persistent diagnosis' system that allows easy testing and quick analysis of results inside the KAIST campus.
Seegene
provides diagnostic reagents for 40,000 COVID-19 tests for the KAIST community.
Seegene supports the conduct of COVID-19 testing and all necessary expenses for
those wishing to be tested among school members by using the ‘Mobile Station,’
a mobile on-site testing laboratory installed inside the KAIST campus.
The
‘Mobile Station’ is a mobile laboratory developed by Seegene that can perform
the entire process of diagnosing COVID-19, from sample collection to PCR test
and the result analysis. KAIST members can check the results in about 3 hours
after undergoing a simple COVID-19 test inside the school, and up to 7,500
people can be tested per day.
CEO
Chun Jong-yoon said, "I am delighted to have a lasting relationship with
KAIST through this donation following the agreement ceremony for joint research
on molecular diagnosis, which we signed in July." He also said, "I
hope this donation will help students return to their normal school life."